PRA Health Sciences, Inc.
PRA Health Sciences, Inc., a leading global contract research organisation (CRO), is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1976, the company has established itself as a pivotal player in the clinical research industry, providing comprehensive services that span from Phase I to Phase IV clinical trials. PRA Health Sciences offers a unique blend of innovative solutions, including data-driven insights and advanced technology platforms, which enhance the efficiency and effectiveness of clinical development. With a strong focus on therapeutic expertise and patient-centric approaches, the company has achieved notable milestones, including significant partnerships and a robust portfolio of successful trials. Recognised for its commitment to quality and operational excellence, PRA Health Sciences continues to solidify its market position, making it a trusted partner for pharmaceutical and biotechnology companies worldwide.
DitchCarbon Score
How does PRA Health Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PRA Health Sciences, Inc.'s score of 50 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PRA Health Sciences, Inc.'s reported carbon emissions
In 2019, PRA Health Sciences, Inc. reported total carbon emissions of approximately 31,296,000 kg CO2e. This figure includes Scope 1 emissions of about 485,000 kg CO2e, primarily from stationary combustion, Scope 2 emissions of around 8,456,000 kg CO2e from purchased electricity, and significant Scope 3 emissions of approximately 22,355,000 kg CO2e, largely attributed to business travel. PRA Health Sciences has set ambitious near-term climate commitments, aiming to reduce both Scope 1 and Scope 2 emissions to near zero by 2025. This commitment reflects a proactive approach to mitigating their carbon footprint and aligns with industry standards for climate action. The emissions data is cascaded from their parent company, ICON Public Limited Company, indicating a corporate family relationship that influences their sustainability initiatives. As a current subsidiary, PRA Health Sciences is part of a broader strategy to enhance environmental performance across the organisation. Overall, PRA Health Sciences is actively working towards significant emissions reductions, demonstrating a commitment to sustainability and climate responsibility within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|
| Scope 1 | - | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 3,945,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 779,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PRA Health Sciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
